RES vs. BTCY

In the year-to-date period, RES achieves a 2.22% return, which is significantly lower than BTCY's 20.77% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for RPC, Inc. (RES) and Biotricity, Inc. (BTCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RES Sharpe Ratio is -0.25, which is comparable to the BTCY Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of RES and BTCY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

RES's dividend yield for the trailing twelve months is around 2.65%, while BTCY has not paid dividends to shareholders.

The maximum RES drawdown since its inception was -92.34%, smaller than the maximum BTCY drawdown of -99.67%. Use the drawdown chart below to compare losses from any high point for RES and BTCY. For additional features, visit the drawdowns tool.

The current volatility for RPC, Inc. (RES) is 12.06%, while Biotricity, Inc. (BTCY) has a volatility of 47.26%. This indicates that RES experiences smaller price fluctuations and is considered to be less risky than BTCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between RPC, Inc. and Biotricity, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.